Eshghi Alireza, Mohammadpour Mehrnaz, Kaviani Nasser, Tahririan Dana, Akhlaghi Najmeh
Torabinejad Dental Research Center and Departments of Pediatric Dentistry, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Pediatrics, School of Dentistry, Shahr-e-kord University of Medical Sciences, Shahr-e-kord, Iran.
Dent Res J (Isfahan). 2016 Jan-Feb;13(1):1-6. doi: 10.4103/1735-3327.174688.
Proper analgesic agents should be used in combination with sedative agents. Remifentanil is a synthetic narcotic/analgesic agent with a short duration effect and decreases the risk of apnea during recovery. Bispectral index system (BIS) is a new noninvasive technique for the evaluation of the depth of sedation. The aim of present clinical trial was to evaluate and compare the efficacy of intravenous sedation with propofol/midazolam/remifentanil (PMR) in comparison to propofol/midazolam/ketamine (PMK) for dental procedures in children 3-7 years of age.
In this clinical trial, 32 healthy uncooperative children who were candidates for dental treatments under sedation were randomly divided into two groups. Intravenous sedation was induced with PMR in one group and with PMK in the other group. After injection and during procedure BIS index, heart rate and respiratory rate, blood pressure, and oxygen saturation was evaluated every 5 min. After the procedure, recovery time was measured. Data were analyzed with ANOVA, Friedman, Wilcoxon, and t-test.
The BIS value was significantly low in ketamin group (P = 0.003) but respiratory rates and heart rates were same in both groups with no statistical difference (P = 0.884, P = 0.775). The recovery time was significantly shorter in remifentanil group (P = 0.008 and P = 0.003).
It can be concluded that intravenous sedation technique with PMR combination induces effective and safe sedation, with less pain and more forgetfulness and a shorter recovery time for children 3-7 years of age during dental procedures.
合适的镇痛药物应与镇静药物联合使用。瑞芬太尼是一种起效迅速的合成麻醉性/镇痛药物,可降低苏醒期呼吸暂停的风险。脑电双频指数系统(BIS)是一种评估镇静深度的新型无创技术。本临床试验的目的是评估和比较丙泊酚/咪达唑仑/瑞芬太尼(PMR)与丙泊酚/咪达唑仑/氯胺酮(PMK)静脉镇静用于3至7岁儿童牙科手术的疗效。
在本临床试验中,32例计划在镇静下接受牙科治疗的健康不合作儿童被随机分为两组。一组采用PMR诱导静脉镇静,另一组采用PMK诱导静脉镇静。注射后及手术过程中,每5分钟评估一次BIS指数、心率、呼吸频率、血压和血氧饱和度。手术后,测量苏醒时间。数据采用方差分析、Friedman检验、Wilcoxon检验和t检验进行分析。
氯胺酮组的BIS值显著较低(P = 0.003),但两组的呼吸频率和心率相同,无统计学差异(P = 0.884,P = 0.775)。瑞芬太尼组的苏醒时间显著缩短(P = 0.008和P = 0.003)。
可以得出结论,PMR联合静脉镇静技术对3至7岁儿童在牙科手术中能诱导有效且安全的镇静,疼痛更少,遗忘性更强,苏醒时间更短。